Back to EUR-Lex homepage

EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search
You are here

Document 62016TN0662

Kawża T-662/16: Rikors ippreżentat fit-12 ta’ Settembru 2016 – Gall Pharma vs EUIPO – Pfizer (Styriagra)

OJ C 441, 28.11.2016, p. 19–20 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

28.11.2016   

MT

Il-Ġurnal Uffiċjali tal-Unjoni Ewropea

C 441/19

Rikors ippreżentat fit-12 ta’ Settembru 2016 – Gall Pharma vs EUIPO – Pfizer (Styriagra)

(Kawża T-662/16)

(2016/C 441/24)

Lingwa tar-rikors: il-Ġermaniż

Partijiet

Rikorrenti: Gall Pharma GmbH (Judenburg, l-Awstrija) (rappreżentanti: D. Reichelt u L. Figura, avukati)

Konvenut: L-Uffiċċju tal-Proprjetà Intellettwali tal-Unjoni Ewropea (EUIPO)

Parti oħra quddiem il-Bord tal-Appell: Pfizer Inc. (New York, New York, l-Istati Uniti)

Informazzjoni dwar il-proċedimenti quddiem l-EUIPO

Applikant għat-trade mark kontenzjuża: ir-rikorrenti

Trade mark kontenzjuża kkonċernata: trade mark verbali tal-Unjoni “Styriagra” – Trade mark tal-Unjoni Nru 12 161 469

Proċedimenti quddiem l-EUIPO: proċedimenti ta’ oppożizzjoni

Deċiżjoni kkontestata: deċiżjoni tal-Ħames Bord tal-Appell tal-EUIPO tat-13 ta’ Ġunju 2016 fil-Każ R 724/2015-5

Talbiet

—

tannulla d-deċiżjoni kkontestata u tiċħad l-oppożizzjoni Numru 002286568 kontra t-trade mark tal-Unjoni Ewropea Nru 000233890;

—

tikkundanna lill-konvenut ibati l-ispejjeż.

Motivi invokati

—

Ksur tal-Artikolu 8(5) tar-Regolament Nru 207/2009;

—

Ksur tal-Artikolu 8(1)(b) tar-Regolament Nru 207/2009.
Top